Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
BMC Infect Dis ; 7: 136, 2007 Nov 19.
Artículo en Inglés | MEDLINE | ID: mdl-18021446

RESUMEN

BACKGROUND: Pathogen-associated molecular patterns (PAMP) receptors play a key role in the early host response to viruses. In this work, we determined mRNA levels of two members of the Toll-like Receptors family, (TLR3 and TLR7) and the helicase RIG-I, all of three recognizing viral RNA products, in peripheral blood of healthy donors and hepatitis C virus (HCV) patients, to observe if their transcripts are altered in this disease. METHODS: IFN-alpha, TLR3, TLR7 and RIG-I levels in peripheral blood from healthy controls (n = 18) and chronic HCV patients (n = 18) were quantified by real-time polymerase chain reaction. RESULTS: Our results show that IFN-alpha, TLR3, TLR7 and RIG-I mRNA levels are significantly down-regulated in patients with chronic HCV infection when compared with healthy controls. We also found that the measured levels of TLR3 and TLR7, but not RIG-I, correlated significantly with those of IFN-alpha CONCLUSION: Monitoring the expression of RNA-sensing receptors like TLR3, TLR7 and RIG-I during the different clinical stages of infection could bring a new source of data about the prognosis of disease.


Asunto(s)
Regulación hacia Abajo , Hepatitis C Crónica/inmunología , Leucocitos Mononucleares/metabolismo , ARN Mensajero/metabolismo , Receptores de Reconocimiento de Patrones/metabolismo , Adulto , Anciano , Proteína 58 DEAD Box , ARN Helicasas DEAD-box/genética , ARN Helicasas DEAD-box/metabolismo , Femenino , Hepacivirus/inmunología , Hepacivirus/patogenicidad , Hepatitis C Crónica/metabolismo , Hepatitis C Crónica/virología , Humanos , Interferón-alfa/genética , Interferón-alfa/metabolismo , Leucocitos Mononucleares/inmunología , Masculino , Persona de Mediana Edad , Pronóstico , ARN Mensajero/genética , ARN Viral/metabolismo , Receptores Inmunológicos , Receptores de Reconocimiento de Patrones/genética , Receptor Toll-Like 3/genética , Receptor Toll-Like 3/metabolismo , Receptor Toll-Like 7/genética , Receptor Toll-Like 7/metabolismo
2.
Anticancer Res ; 25(3B): 1945-51, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16158929

RESUMEN

BACKGROUND: We have previously demonstrated that the synthetic retinoid N-(4-hydroxyphenyl) retinamide (4-HPR) induces the overproduction of reactive oxygen species (ROS) in human leukemia cells, which in turn triggers the intrinsic (mitochondrial) apoptotic pathway. In order to study the role of glutathione in 4-HPR-induced apoptosis, the levels of this antioxidant were analyzed in cell lines which are sensitive and resistant to the effects of 4-HPR, and the effect of the modulation of glutathione levels on 4-HPR cytotoxicity was characterized. MATERIALS AND METHODS: Mitochondrial membrane potential (deltaPsim) and the levels of glutathione were measured by flow cytometry. A fluorometric assay was used to measure intracellular ROS generation and Western blot was employed to analyze tissue transglutaminase expression. RESULTS: 4-HPR generated large quantities of ROS in cell lines which expressed low glutathione levels, these cells being the most sensitive to the retinoid. The sensitivity of leukemia cells to 4-HPR could be modulated, either by increasing intracellular glutathione contents using all-trans retinoic acid (ATRA), or by decreasing it using DL-buthionine-S,R-sulfoximine (BSO). ATRA increased the level of expression of tissue transglutaminase, whereas inhibition of this enzyme led to enhanced apoptosis. CONCLUSION: Our findings indicate that the glutathione content contributes to determining the sensitivity of cells to 4-HPR and points to the potential application of glutathione-inhibiting agents as enhancers in 4-HPR-based therapies.


Asunto(s)
Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Fenretinida/farmacología , Glutatión/metabolismo , Protocolos de Quimioterapia Combinada Antineoplásica/farmacología , Apoptosis/fisiología , Butionina Sulfoximina/administración & dosificación , Butionina Sulfoximina/farmacología , Cadaverina/análogos & derivados , Cadaverina/farmacología , Línea Celular Tumoral , Inhibidores Enzimáticos/farmacología , Fenretinida/administración & dosificación , Humanos , Células Jurkat , Leucemia de Células T/tratamiento farmacológico , Leucemia de Células T/enzimología , Leucemia de Células T/metabolismo , Leucemia de Células T/patología , Estrés Oxidativo/efectos de los fármacos , Transglutaminasas/antagonistas & inhibidores , Transglutaminasas/biosíntesis , Transglutaminasas/metabolismo , Tretinoina/administración & dosificación , Tretinoina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA